Logo

Biotrin Launches MDx Project for DNA, RNA Detection

Jun 18, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Irish diagnostics firm Biotrin announced today a new R&D project to develop automated molecular diagnostics platform technology and assay reagents to detect target DNA and RNA in infectious diseases.

The technology will be based on loop-mediated isothermal amplification, which uses a single temperature incubation.

The project is expected to create 40 new jobs.

Biotrin, owned by Italian firm Diasorin, is based in Dublin, Ireland, and its products include tests for parvovirus B19, HHV-6, HHV-8, and human metapneumovirus.

Filed under

Diagnostics
PCR
LAMP
ABRF
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.